BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna Corporation (NYSE: CI), a leading global health service company, has successfully completed its combination with Express Scripts Holding Company (“Express ...

Express Scripts is making smart inhalers available to its members who suffer from asthma or COPD. The move potentially represents a big win for Propeller Health, which now has a chance to provide its ...

Please provide your email address to receive an email when new articles are posted on . Express Scripts will prefer Viatris’ insulin glargine-yfgn injection, the first FDA-approved interchangeable ...

Cigna Corp. and Express Scripts said they closed their merger on Thursday, less than a year after the companies first agreed to combine in a deal that further transforms the healthcare landscape.

The delivery of pharmaceuticals to consumers involves many firms along the supply chain, and Express Scripts’ core pharmacy benefit manager service assists pharmaceutical benefit payers with the ...

Health insurer Cigna reached a deal to acquire pharmacy benefits manager Express Scripts for about $54 billion as players inside and outside the industry jockey to transform the health care landscape.

Health insurance giant Cigna is buying Express Scripts, the company that administers prescription drug insurance plans for millions of Americans, in a deal worth $67 billion, including $15 billion in ...

It's easy to see why EpiPen has become the focus of America's fury over drug prices. It treats potentially deadly allergic reactions — for example, in a child who is stung by a bee — and its price has ...

The Federal Trade Commission is targeting the three largest pharmacy benefit managers over rebate schemes that allegedly inflate insulin prices for some consumers. “This perverse system results in ...

In a lawsuit filed this week, Ohio Attorney General Dave Yost accused pharmacy benefit managers Express Scripts and Prime Therapeutics of using a little-known company based in Switzerland to drive up ...

Express Scripts, Inc. sued the Federal Trade Commission on Tuesday over a report the pharmacy benefit management company called "unfair, biased, erroneous and defamatory." Headquartered in North St.